Z-drug withdrawal guideline combines a literature review with expert consensus
Brazilian specialists outline how clinicians might assess dependence and manage discontinuation, but the abstract reports recommendations rather than patient outcomes from testing a withdrawal strategy.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This guideline addresses dependence on Z-drugs used for insomnia and how clinicians manage discontinuation. Its recommendations combine a literature review with expert consensus. The abstract describes assessment, gradual tapering and psychological support, but supplies no patient outcome results showing how well the proposed approach works or how it compares with alternatives.
The abstract provides no treatment effect estimates, evidence grades or comparisons of withdrawal strategies. It does not show whether the recommended approach improves withdrawal success or reduces adverse effects.
How guidance was developed
A multidisciplinary task force used a systematic review to develop recommendations, then refined them through a Delphi process. Neurology and addiction specialists helped select the literature and participated in voting on the guidance.
What the recommendations cover
The guidance covers assessment of dependence, mental health and sleep conditions before discontinuation. It also discusses gradual tapering and psychological approaches, including cognitive behavioral therapy for insomnia, as recommendations for clinical management rather than tested results.
The original publication
Z-drug abuse and dependence: clinical guideline of the Brazilian Academy of Neurology for diagnosis and management.
Stelzer FG, Bacelar A, Éckeli AL et al.
Arq Neuropsiquiatr · 2025
- PubMed ID
- 41187937
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.